Natera, Inc. is 6.4x more valuable than Caris Life Sciences, Inc. by market capitalization ($30.83 B vs $4.85 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NTRA | CAI |
|---|---|---|
| Market cap | $30.83 B | $4.85 B |
| US-listed rank | #451 | #1404 |
| Revenue (latest FY) | $2.31B | $812.03M |
| Net income (latest FY) | -$208.16M | -$68.09M |
| Net margin | -9.0% | -8.4% |
| SEC filings | 1,695 | 102 |
Natera, Inc. is 6.4x more valuable than Caris Life Sciences, Inc. by market capitalization ($30.83 B vs $4.85 B).
In their latest fiscal years, Natera, Inc. reported $2.31B in revenue while Caris Life Sciences, Inc. reported $812.03M.
Full pages: Natera, Inc. and Caris Life Sciences, Inc., or browse the full rankings.